CCL5 and neuroblastoma: Dedoni et al. [12] found in SH-SY5Y neuroblastoma cells that CCL5 activates the AKT and MAPK pathways via GPR75 through the Gαq protein pathway, thereby exerting anti-apoptotic and neuroprotective effects.